Transnational Cannabis Ltd (TRCNF)

[Nosnibor]

"WLDCF could be your ticket to double-digit gains...

http://stockreads.com/Stock-Newsletter.aspx?id=93320#ixzz5oVaTKkiK

"It`s Official – The Biggest Cannabis Merger In Europe Just Happened - Sending Shock-Waves Through The Entire Global Pot Stock Sector!Dear Fellow Trader,Turn back the clock 6 years, before there were over 10 publicly-traded, billion-dollar cannabis companies in North America.This is where Europe is right now, and ICC International Cannabis (WLDCF) is a global Cannabis leader, with exposure to a broader range of countries than any competitor to date – focusing on Europe!Cannabis is Europe`s MOST promising hyper-growth sector.Immediately turn your attention to ICC International Cannabis Corp (WLDCF)ICC International Cannabis is the ONLY company taking giant strides to dominate the European cannabis industry.ICC International Cannabis crushes the competition in terms of a global asset portfolio, that`s how dominating this stock is, when it comes to international exposure.ICC International Cannabis has establish a worldwide footprint that allows it to draw from the entirety of the global cannabis industry. The company has already amassed an impressive portfolio of holdings that spans 18 countries and 4 continents.Through its portfolio of subsidiaries, WLDCF has proven that it has operating assets and is developing a world-class platform for cultivation, extraction, formulation and distribution across the globe in the United Kingdom, Denmark, Poland, Switzerland, Germany, Macedonia, Bulgaria, Serbia, Croatia, Greece, Italy, Portugal, Malta, Colombia, Argentina, Australia, South Africa and Lesotho.While Germany and Italy are expected to lead the way in medical cannabis sales in Europe, it makes a lot of sense for WLDCF to set its sights on the European Union (EU) and its 40 sovereign nations as a whole.After all, while the U.S. and Canada’s combined population of about 360 mil people have North America at the epicenter of legal cannabis sales globally, Europe’s population is more than double that at over 740 mil potential customers.Europe is a burgeoning cannabis market; however, with a budget of $1.79 Tril in healthcare spending, Arcview and BDS report that European government-subsidized healthcare systems will catapult medical cannabis to dominate Europe’s cannabis market and become the largest medical marijuana market in the world.It will be companies that are first-to-market with significant “start-to-finish” solutions for cultivating, extracting, formulating and distributing cannabis products like the platform that WLDCF is developing that will secure significant market share in Europe.Given the industry’s potential and the explosive growth opportunities there, realistically, companies who are “first movers” in Europe could become some of the largest cannabis companies in the world.While things are changing quickly in Europe, the EU’s move to a legal cannabis market is gaining traction, and currently the entire market is based upon medical cannabis that must be purchased in pharmacies after a patient obtains a doctor’s prescription.Germany took the lead in the EU in 2017 by opening up cannabis for medical use in pharmacies, which almost immediately increased patients seeking medical cannabis from just a few hundred patients to tens of thousands.For every hurdle that the legal cannabis market in the EU presents, WLDCF has meticulously pieced together asset after asset to brilliantly navigate its way through the proverbial EU puzzle and each of its potential roadblocks.Since medical cannabis is considered a pharmaceutical product in Europe, all products must be fully Good Manufacturing Practice or “GMP” and ISO certified—no problem—WLDCF announced that it has that covered with the Ebersbach facility in Germany.Keeping in mind that the EU’s entire legal cannabis market is for medical use and can only be purchased legally through pharmacies, the most brilliant move by WLDCF to date may just be the company’s agreement with Evergreen Pacific Insurance Corporation and Cannops Consulting, who will collaborate to introduce transformative extended healthcare coverage, including cannabinoid therapeutic coverage, to the European marketplace and the EU’s 1.6 Mil healthcare practitioners.Collectively the three entities will pursue a joint venture partnership for the purpose of launching Evergreen Pacific’s revolutionary “BuyWell” Ecosystem across Europe, including:

• First of its kind transformative coverage for cannabinoid therapeutic treatment via the BuyWell Care platform; • Online medical cannabis coverage utilizing a proprietary pricing methodology; • Streamlined access to top-tier alternative healthcare services; • CBD Health and Wellness e-commerce marketplace; and • Educational platform for medical practitioners.

And, of course, the next obvious hurdle would be demand.Demand for product would skyrocket if WLDCF can make such a significant entrance into the EU’s medical cannabis marketplace with the aforementioned agreement.Seemingly leaving no stone unturned, WLDCF has that covered as well with a recent announcement to purchase 155 metric tonnes, which is around 342,000 U.S. pounds, of processed industrial hemp from Eviana Health Corporation.Additionally, WLDCF has simultaneously entered into a definitive agreement to acquire 100% of Future Hemp Corp., which holds an exclusive supply agreement for the delivery of 400 metric tonnes (882,000 pounds) of certified organic hemp from a licensed Croatian producer.The company says that this acquisition closes the loop for WLDCF in the EU, as it now offers:

• Local presence in 13 European countries via licensing or off-take agreements, • Supply on hand of product ready for sale starting in Q2 2019, • An experienced operational team via the 49.9% acquisition of Wayland’s assets and license portfolio, including the ability to formulate and produce various product lines.

• Soon to be announced world class brands, • 39,000 retail outlets for distribution, and • Europe’s first dedicated insurance program for medical cannabis patients.

Essentially WLDCF has created a circle or a start-to-finish solution for the EU—from local production, to remarkable brands to patient support that the company believes is unparalleled in the European market today.Ironically, as WLDCF continues to acquire assets to further its global growth strategy and offer real solutions for the industry, it could potentially, very well be setting itself up as an attractive acquisition target for a company like Canopy Growth (NYSE: CGC) for instance.As you can see, they have taken major steps over the past two years to become one of the largest GLOBAL cannabis-focused companies on the planet.The company is in rapid expansion mode right now strengthening its footprint at light-speed pace in the global cannabis sector, recently announcing not one, not two, but multiple significant breaking developments like; WLDCF is now included in the Largest Canadian cannabis ETF Exchange-Traded Fund, the Horizons Marijuana Life Sciences ETF, with over $1BIL in assets under management...For example, the Horizons Marijuana Life Sciences ETF (HMMJ) OLNY invests in the sectors top stocks—companies like Canopy Growth, Tilray, and Cronos Group.It has over a $1BIL in assets…They also recently announced they`re pursuing an up-listing on the NASDAQ, the New York Stock Exchange (the “NYSE”) or the Alternative Investment Market (“AIM”), a division of the London Stock Exchange (the “LSE”).The Bottom Line…The Worldwide Legal Cannabis Industry is Exploding Exponentially!ICC International Cannabis is capitalizing on the rapid legalization of cannabis worldwide and the growth of the industry by growing equally as fast with an extensive global footprint that extends to many of those same new-to-the-market countries.There is NO BETTER TIME than Right Now to consider Mondays New Profile... ICC International Cannabis Corp (WLDCF)I am urging all of our members to add WLDCF to the top of their watch list right now, and be ready this morning at the opening bell...#1 Newsletter Longest Running MicroCap Newsletter Editor In Chief, OTCtipReporterDON`T MISS ANOTHER HOT OPPORTUNITY TO MAKE HUGE PROFITS!None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any dec. ision. to in. .vest. in any such company or other financial decisions should not be made based upon the information provide herein. Instead we strongly urge you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10Q, 10K, Form 8K, insider reports, Forms 3, 4, 5 Schedule 13D. We are compliant with the Can Spam Act of 2003. We do not offer such ad.vice or an a.n.a. ly.sis, and we further urge you to consult your own independent tax, busin.ess, fina.ncial and inves.tment adv.isors. Inve.sting in micro-cap and growth sec.ur.ities is highly spec....ulative and carries and extremely high degree of risk. It is possible that an investor`s investment may be lost or impaired due to the speculative nature of the compa..ies profiled. The Priv..ate Secur.ites Litigation Reform Act of 1995 provides inve.stors a `safe harbor` in regard to forward-looking statements. Any statements that express or involve discu.ssions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or perfor.mance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of ri..sks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions & quote; "may", "could", or "might" occur. Understand there is no guaran - tee past performance will be indicative of future results. In preparing this publication, we have relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such liability cannot be guaran - teed. Inv.estors should not rely on the information contained in this website or newsletter. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertis.ements in this website are believed to be reliable, however, we and its owners, affiliates, subsidiaries, officers, directors, representatives and agents dis-cla im any lia.bility as to the completeness or accuracy of the information contained in any adverti.sement and for any omissions of materials facts from such advertisement. We are not responsible for any claims made by the companies advertised herein, nor are we responsible for any other promotional firm, its program or its structure. This message is meant for informational and educational purposes only and does not provide inv.est.ment a.dvi.ce. Never make inv.estment decisions based on a.ything we say. To date we have been compensated $105K USD cash via bank wire by a third party to profile International Cannabis Corp. We have been compensated an additional $15K USD cash via bank wire by a third party to conduct investor relations advertising and marketing for International Cannabis Corp. We do not own shares".

OTC Tip Reporter 4417 13th St. Saint Cloud, FL 34769 To

Read more: http://stockreads.com/Stock-Newsletter.aspx?id=93320#ixzz5oVafMP3u